Takeda’s $770M deal deepens Big Pharma’s omics push

Takeda’s $770M deal deepens Big Pharma’s omics push

Submitted by admin on March 14, 2025 - 11:18am
Source: 
Pharma Voice
News Tags: 
Takeda
chemoproeomics
drug discovery
BridGene Biosciences
Headline: 
Takeda’s $770M deal deepens Big Pharma’s omics push
snippet: 

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

Do Not Allow Advertisers to Use My Personal information